NeoGenomics (NASDAQ:NEO – Free Report) had its target price cut by TD Cowen from $22.00 to $19.00 in a research note released on Friday morning, Benzinga reports. They currently have an outperform rating on the medical research company’s stock. A number of other research analysts have also recently commented on NEO. Morgan Stanley upped their […]
Guggenheim began coverage on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a report issued on Thursday morning, MarketBeat reports. The firm issued a buy rating and a $60.00 price objective on the stock. A number of other brokerages also recently commented on TXG. Wolfe Research initiated coverage on 10x Genomics in a research […]
Handelsbanken Fonder AB lifted its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 4.2% in the second quarter, Holdings Channel.com reports. The institutional investor owned 14,900 shares of the company’s stock after acquiring an additional 600 shares during the period. Handelsbanken Fonder AB’s holdings in 10x Genomics were worth $832,000 at […]
Rhenman & Partners Asset Management AB boosted its position in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 100.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 150,000 shares of the company’s stock after purchasing an additional […]
North Star Asset Management Inc. lifted its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 14.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41,075 shares of the company’s stock after purchasing an additional 5,126 shares during […]